RecruitingPhase IEN originalLung cancerMetastatic / advanced

A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

This study will test whether valemetostat in combination with atezolizumab is a safe treatment that causes few or mild side effects in people with extensive-stage small cell lung cancer (SCLC). The researchers will test different doses of valemetostat to find the highest dose that causes few or mild side effects in participants. After the dose is found, researchers will test it in a new group of participants to learn more about the safety of the study treatment and see if it is an effective treatment for extensive-stage SCLC.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Wiek minimum 18 lat
  • Potwierdzony diagnozą zaawansowany rak płuc typu drobnokomórkowego
  • Leczenie wstępne chemioterapią złotem platyny połączoną z atezolizumabem (4 cykle)
  • Możliwość rozpoczęcia badania w ciągu 4 tygodni po zakończeniu leczenia
  • Prawidłowe wyniki badań krwi i funkcja nerek i wątroby
  • Oczekiwana przeżywalność minimum 12 tygodni
  • Podpisana świadoma zgoda na udział w badaniu
  • Dobry ogólny stan zdrowia (ocena ECOG 0 lub 1)

✗ Disqualifies

  • Nieskontrolowane choroby zakaźne lub uogólnione zaburzenia krzepnięcia krwi

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
August 11, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (7)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, United States

Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)

Commack, United States

Memorial Sloan Kettering Westchester

Harrison, United States

Memorial Sloan Kettering Cancer Center

New York, United States

Memorial Sloan Kettering Nassau (Limited Protocol Activities)

Uniondale, United States

Trial contact

Mark Awad, MD

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/12/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.